These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 26269398)

  • 1. Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score.
    Schoels MM; Aletaha D; Alasti F; Smolen JS
    Ann Rheum Dis; 2016 May; 75(5):811-8. PubMed ID: 26269398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Composite Indices Tailored for Psoriatic Arthritis Treated with csDMARD and bDMARD: A Cross-sectional Analysis of a Longitudinal Cohort.
    Lubrano E; De Socio A; Perrotta FM
    J Rheumatol; 2017 Aug; 44(8):1159-1164. PubMed ID: 28572467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Burden of Psoriatic Arthritis According to Different Definitions of Disease Activity: Comparing Minimal Disease Activity and the Disease Activity Index for Psoriatic Arthritis.
    Wervers K; Vis M; Tchetveriko I; Gerards AH; Kok MR; Appels CWY; van der Graaff WL; van Groenendael JHLM; Korswagen LA; Veris-van Dieren JJ; Hazes JMW; Luime JJ
    Arthritis Care Res (Hoboken); 2018 Dec; 70(12):1764-1770. PubMed ID: 29609220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Different Remission and Low Disease Definitions in Psoriatic Arthritis and Evaluation of Their Prognostic Value.
    Coates LC; Gottlieb AB; Merola JF; Boone C; Szumski A; Chhabra A
    J Rheumatol; 2019 Feb; 46(2):160-165. PubMed ID: 30323006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remission and low disease activity in psoriatic arthritis publications: a systematic literature review with meta-analysis.
    Hagège B; Tan E; Gayraud M; Fautrel B; Gossec L; Mitrovic S
    Rheumatology (Oxford); 2020 Aug; 59(8):1818-1825. PubMed ID: 32118267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of disease activity index for psoriatic arthritis (DAPSA) and minimal disease activity (MDA) targets for patients with psoriatic arthritis: A post hoc analysis of data from phase 3 tofacitinib studies.
    Schneeberger EE; Citera G; Nash P; Smolen JS; Mease PJ; Soriano ER; Helling C; Szumski AE; Mundayat R; de León DP
    Semin Arthritis Rheum; 2023 Feb; 58():152134. PubMed ID: 36476498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residual symptoms and disease burden among patients with psoriatic arthritis: is a new disease activity index required?
    Kilic G; Kilic E; Nas K; Kamanlı A; Tekeoglu İ
    Rheumatol Int; 2019 Jan; 39(1):73-81. PubMed ID: 30426235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of remission and low disease activity states with DAPSA, MDA and VLDA in a clinical trial setting in psoriatic arthritis patients: 2-year results from the FUTURE 2 study.
    Coates LC; Nash P; Kvien TK; Gossec L; Mease PJ; Rasouliyan L; Pricop L; Jugl SM; Gandhi KK; Gaillez C; Smolen JS
    Semin Arthritis Rheum; 2020 Aug; 50(4):709-718. PubMed ID: 32521325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Very Low Disease Activity, DAPSA Remission, and Impact of Disease in a Spanish Population with Psoriatic Arthritis.
    Queiro R; Cañete JD; Montilla C; Abad MA; Montoro M; Gómez S; Cábez A;
    J Rheumatol; 2019 Jul; 46(7):710-715. PubMed ID: 30709957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of composite disease activity scores in psoriatic arthritis to the PRESTA data set.
    FitzGerald O; Helliwell P; Mease P; Mumtaz A; Coates L; Pedersen R; Nab H; Molta C
    Ann Rheum Dis; 2012 Mar; 71(3):358-62. PubMed ID: 21989542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early psoriatic arthritis: short symptom duration, male gender and preserved physical functioning at presentation predict favourable outcome at 5-year follow-up. Results from the Swedish Early Psoriatic Arthritis Register (SwePsA).
    Theander E; Husmark T; Alenius GM; Larsson PT; Teleman A; Geijer M; Lindqvist UR
    Ann Rheum Dis; 2014 Feb; 73(2):407-13. PubMed ID: 23355078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease activity and response assessment in psoriatic arthritis using the Disease Activity index for PSoriatic Arthritis (DAPSA). A brief review.
    Smolen JS; Schoels M; Aletaha D
    Clin Exp Rheumatol; 2015; 33(5 Suppl 93):S48-50. PubMed ID: 26471734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the Disease Activity index for PSoriatic Arthritis (DAPSA) with a quick quantitative C reactive protein assay (Q-DAPSA) in patients with psoriatic arthritis: a prospective multicentre cross-sectional study.
    Proft F; Schally J; Brandt HC; Brandt-Juergens J; Burmester GR; Haibel H; Käding H; Karberg K; Lüders S; Muche B; Protopopov M; Rademacher J; Rios Rodriguez V; Torgutalp M; Verba M; Zinke S; Poddubnyy D
    RMD Open; 2022 Nov; 8(2):. PubMed ID: 36323487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Need for Improvement in Current Treatment of Psoriatic Arthritis: Study of an Outpatient Clinic Population.
    Michelsen B; Diamantopoulos AP; Høiberg HK; Soldal DM; Kavanaugh A; Haugeberg G
    J Rheumatol; 2017 Apr; 44(4):431-436. PubMed ID: 28148701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimal Disease Activity and Remission in Psoriatic Arthritis Patients Treated with Anti-TNF-α Drugs.
    Perrotta FM; Marchesoni A; Lubrano E
    J Rheumatol; 2016 Feb; 43(2):350-5. PubMed ID: 26669925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient's Global Assessment as an Outcome Measure for Psoriatic Arthritis in Clinical Practice: A Surrogate for Measuring Low Disease Activity?
    Lubrano E; Perrotta FM; Parsons WJ; Marchesoni A
    J Rheumatol; 2015 Dec; 42(12):2332-8. PubMed ID: 26523033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing patient-perceived and physician-perceived remission and low disease activity in psoriatic arthritis: an analysis of 410 patients from 14 countries.
    Gorlier C; Orbai AM; Puyraimond-Zemmour D; Coates LC; Kiltz U; Leung YY; Palominos P; Cañete JD; Scrivo R; Balanescu A; Dernis E; Tälli S; Ruyssen-Witrand A; Soubrier M; Aydin SZ; Eder L; Gaydukova I; Lubrano E; Kalyoncu U; Richette P; Husni ME; de Wit M; Smolen JS; Gossec L
    Ann Rheum Dis; 2019 Feb; 78(2):201-208. PubMed ID: 30442648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease activity states of the DAPSA, a psoriatic arthritis specific instrument, are valid against functional status and structural progression.
    Aletaha D; Alasti F; Smolen JS
    Ann Rheum Dis; 2017 Feb; 76(2):418-421. PubMed ID: 27457512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can disease activity in patients with psoriatic arthritis be adequately assessed by a modified Disease Activity index for PSoriatic Arthritis (DAPSA) based on 28 joints?
    Michelsen B; Sexton J; Smolen JS; Aletaha D; Krogh NS; van der Heijde D; Kvien TK; Hetland ML
    Ann Rheum Dis; 2018 Dec; 77(12):1736-1741. PubMed ID: 30237203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disparity between ultrasound and clinical findings in psoriatic arthritis.
    Husic R; Gretler J; Felber A; Graninger WB; Duftner C; Hermann J; Dejaco C
    Ann Rheum Dis; 2014 Aug; 73(8):1529-36. PubMed ID: 23740228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.